Submission of the drug for FDA approval for weight loss is expected after completion of a second phase 3 trial, SURMOUNT-2, in spring 2023
There's no one-size-fits-all approach when it comes to optimizing your wellness
Mary My experience has been great with Genesis
Why the cost difference exists Eli Lilly spent billions developing tirzepatide through clinical trials, regulatory submissions, and manufacturing infrastructure
The sleep disruption mechanism has a directly testable intervention: medication timing
While there are already great weight loss medications on the market that have given plenty of people success, it doesnt hurt to have other alternatives, says Mir Ali, MD, medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, CA